Nephrotic-range proteinuria on interferon-β treatment: Immune-induced glomerulonephritis or other pathway?

6Citations
Citations of this article
13Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

We present a case report of a 37-year-old woman with multiple sclerosis (MS) who developed nephrotic-range proteinuria secondary to membrano proliferative glomerulonephritis (MPGN)-like disease with mesangial C3 deposition without evidence of immune-complex deposition in the context of long-term interferon-β (IFN-β) therapy. The complete remission of proteinuria following cessation of IFN-β, strongly suggests causality. To our knowledge, this is the second case report of MPGN associated with IFN-β use. This being the case, the negative immune screen, normal inflammatory markers and the absence of immune complex deposits would imply a different pathway to that previously suggested. © 2014 © The Author 2014. Published by Oxford University Press on behalf of ERA-EDTA. All rights reserved.

Cite

CITATION STYLE

APA

Yuste, C., Rapalai, M., Pritchard, B. A., Jones, T. J., Tucker, B., & Ramakrishna, S. B. (2014). Nephrotic-range proteinuria on interferon-β treatment: Immune-induced glomerulonephritis or other pathway? Clinical Kidney Journal, 7(2), 190–193. https://doi.org/10.1093/ckj/sfu016

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free